Phase 2 Studies: AVX-201

(currently recruiting)

​

AVX-201 is a double blind randomised Phase 2 study in adolescents and children with peanut allergy. The aims of the trial are to evaluate the efficacy and safety of PVX108 when administered intradermally in monthly doses over a 12 month period. The AVX-201 trial is being run under an IND and is currently recruiting at clinics in Australia and the United States.

Interested in participating?
Find out more on ClinicalTrials.gov or contact the trial centre nearest you (details below)